The following media introduced the business alliance between FRONTEO Life Science AI Business Headquarters and Kyowa Pharmaceutical Industry regarding the dementia diagnosis support AI system.

(Order of the Japanese syllabary)

≪Newspaper≫

■ Daily pharmaceutical industry (with 2020/3/3)
Kyowa Pharmaceutical and dementia diagnosis support system form a business alliance. With FRONTEO for information analysis with AI

■ Nikkei Sangyo Shimbun (2020 pages with 3/4/8)
Kyowa Pharmaceutical Industry Partnership for Dementia Diagnosis

■ Yakuji Nippo (2020 pages with 3/4/7)
Business tie-up with Fronteo-Kyowa Pharmaceutical Industry Co., Ltd. for diagnosis of dementia using AI

≪WEB media≫

■ ITmedia News AI +
Supporting dementia diagnosis with AI FRONTEO and Kyowa Pharmaceutical collaborate for practical use in the medical field
https://www.itmedia.co.jp/news/articles/2003/02/news145.html

■ Daily pharmaceutical industry
Kyowa Pharmaceutical, business tie-up with dementia diagnosis support system With FRONTEO for information analysis with AI
https://nk.jiho.jp/article/149282

■ Nikkei electronic version
Kyowa Pharmaceutical to partner with AI diagnosis of cognitive function
https://www.nikkei.com/article/DGXMZO56267980S0A300C2000000/

■ Mynavi News
Kyowa Pharmaceutical Industry and FRONTEO form a partnership with AI-based dementia diagnosis support system
https://news.mynavi.jp/article/20200302-986303/

■ Mix online
Business tie-up with Kyowa Pharmaceutical for "dementia diagnosis support system" utilizing FRONTEO AI Aiming for Japan's first regulatory approval
https://www.mixonline.jp/tabid55.html?artid=68877

■ Ledgi ai
AI is used to diagnose dementia, and dysfunction and severity are judged in about 10 minutes of conversation.
https://ledge.ai/dementia-ai-kyowayakuhin-fronteo/